Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Engagement in the Hepatitis C Care Cascade Among Homeless Veterans, 2015.

Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backus LI.

Public Health Rep. 2017 Mar/Apr;132(2):136-139. doi: 10.1177/0033354916689610. Epub 2017 Jan 30.

PMID:
28135425
2.

Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.

Davitkov P, Chandar AK, Hirsch A, Compan A, Silveira MG, Anthony DD, Smith S, Gideon C, Bonomo RA, Falck-Ytter Y.

PLoS One. 2016 Oct 14;11(10):e0163945. doi: 10.1371/journal.pone.0163945. eCollection 2016.

3.
4.

Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population.

Krishnamurthy P, Hazratjee N, Opris D, Agrawal S, Markert R.

J Gastrointest Oncol. 2016 Jun;7(3):426-32. doi: 10.21037/jgo.2016.01.09.

5.

Disparities in hepatitis C testing in U.S. veterans born 1945-1965.

Sarkar S, Esserman DA, Skanderson M, Levin FL, Justice AC, Lim JK.

J Hepatol. 2016 Aug;65(2):259-65. doi: 10.1016/j.jhep.2016.04.012. Epub 2016 Apr 27.

6.

Chronic Hepatitis C: Treatment, Complications, and Long-term Outcomes in a Population of Latino Veterans.

Santiago-Rolón A, Purcell D, Grigg N, Toro DH.

P R Health Sci J. 2016 Mar;35(1):30-4.

7.

Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis.

Yang S, Wang D, Zhang Y, Yu C, Ren J, Xu K, Deng M, Tian G, Ding C, Cao Q, Li Y, Chen P, Xie T, Wang C, Wang B, Yao J, Threapleton D, Mao C, Ruan B, Li L.

Medicine (Baltimore). 2015 Nov;94(47):e1893. doi: 10.1097/MD.0000000000001893. Review.

8.

Veterans Affairs Office of Research and Development: Research Programs and Emerging Opportunities in Digestive Diseases Research.

O'Leary TJ, Dominitz JA, Chang KM.

Gastroenterology. 2015 Dec;149(7):1652-61. doi: 10.1053/j.gastro.2015.10.021. Epub 2015 Oct 23. Review. No abstract available.

9.

Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C.

Chidi AP, Rogal S, Bryce CL, Fine MJ, Good CB, Myaskovsky L, Rustgi VK, Tsung A, Smith KJ.

Hepatology. 2016 Feb;63(2):428-36. doi: 10.1002/hep.28327. Epub 2015 Dec 21.

10.

Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma.

Hwa KJ, Dua MM, Wren SM, Visser BC.

HPB (Oxford). 2015 Dec;17(12):1124-9. doi: 10.1111/hpb.12508. Epub 2015 Sep 16.

11.

Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.

Flemming JA, Saxena V, Shen H, Terrault NA, Rongey C.

Dig Dis Sci. 2016 Jan;61(1):62-9. doi: 10.1007/s10620-015-3865-8. Epub 2015 Sep 12.

12.

Pain-related anxiety mediates the relationship between depressive symptoms and pain interference in veterans with hepatitis C.

Adams MH, Lovejoy TI, Turk DC, Dobscha SK, Hauser P, Morasco BJ.

Gen Hosp Psychiatry. 2015 Nov-Dec;37(6):533-7. doi: 10.1016/j.genhosppsych.2015.07.003. Epub 2015 Jul 17.

13.

Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications.

Hauser P, Kern S.

World J Hepatol. 2015 Jul 28;7(15):1921-35. doi: 10.4254/wjh.v7.i15.1921. Review.

14.

Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009.

Gundlapalli AV, Nelson RE, Haroldsen C, Carter ME, LaFleur J.

PLoS One. 2015 Jul 13;10(7):e0132056. doi: 10.1371/journal.pone.0132056. eCollection 2015.

15.

Impact of race/ethnicity and gender on HCV screening and prevalence among U.S. veterans in Department of Veterans Affairs Care.

Backus LI, Belperio PS, Loomis TP, Mole LA.

Am J Public Health. 2014 Sep;104 Suppl 4:S555-61. doi: 10.2105/AJPH.2014.302090.

16.

Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.

Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F.

Hepatology. 2014 Dec;60(6):1871-8. doi: 10.1002/hep.27337. Epub 2014 Oct 29.

17.

Estimating the true prevalence of hepatitis C in rhode island.

Kinnard EN, Taylor LE, Galárraga O, Marshall BD.

R I Med J (2013). 2014 Jul 1;97(7):19-24. Review.

18.

Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009.

Suryaprasad A, Byrd KK, Redd JT, Perdue DG, Manos MM, McMahon BJ.

Am J Public Health. 2014 Jun;104 Suppl 3:S350-8. doi: 10.2105/AJPH.2013.301645. Epub 2014 Apr 22.

19.

Expanded use of aggressive therapies improves survival in early and intermediate hepatocellular carcinoma.

Ho EY, Cozen ML, Shen H, Lerrigo R, Trimble E, Ryan JC, Corvera CU, Monto A; HOVAS Group (Hepatocellular Carcinoma Treatment Outcome at VA San Francisco).

HPB (Oxford). 2014 Aug;16(8):758-67. doi: 10.1111/hpb.12214. Epub 2014 Jan 28.

20.

Impact of rural residence and health system structure on quality of liver care.

Rongey C, Shen H, Hamilton N, Backus LI, Asch SM, Knight S.

PLoS One. 2013 Dec 26;8(12):e84826. doi: 10.1371/journal.pone.0084826. eCollection 2013.

Supplemental Content

Support Center